Global Sacral Neuromodulation System Market Growth (Status and Outlook) 2025-2031

According to this study, the global Sacral Neuromodulation System market size will reach US$ million by 2031.

Sacral neuromodulation, also known as sacral nerve stimulation, is a type of electrical stimulation. Sacral neuromodulation system is an implanted system that can help improve the functioning of the bladder by sending electrical signals to the nerves, which control bladder activities.

United States market for Sacral Neuromodulation System is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Sacral Neuromodulation System is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Sacral Neuromodulation System is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Sacral Neuromodulation System players cover Medtronic, Inc. (US), Boston Scientific Corporation (US), St. Jude Medical, Inc. (US), Synapse Biomedical, Inc. (US), Nevro Corporation (US), etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Sacral Neuromodulation System Industry Forecast” looks at past sales and reviews total world Sacral Neuromodulation System sales in 2024, providing a comprehensive analysis by region and market sector of projected Sacral Neuromodulation System sales for 2025 through 2031. With Sacral Neuromodulation System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sacral Neuromodulation System industry.

This Insight Report provides a comprehensive analysis of the global Sacral Neuromodulation System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Sacral Neuromodulation System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Sacral Neuromodulation System market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sacral Neuromodulation System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sacral Neuromodulation System.

This report presents a comprehensive overview, market shares, and growth opportunities of Sacral Neuromodulation System market by product type, application, key players and key regions and countries.

Segmentation by Type:
Internal Neuromodulation System
External Neuromodulation System

Segmentation by Application:
Spinal Cord Stimulation
Deep Brain Stimulation
Sacral Nerve Stimulation
Vagus Nerve Stimulation

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Medtronic, Inc. (US)
Boston Scientific Corporation (US)
St. Jude Medical, Inc. (US)
Synapse Biomedical, Inc. (US)
Nevro Corporation (US)
Neurosigma, Inc. (US)
Neuropace, Inc. (US)
Neuronetics, Inc. (US)
Cyberonics, Inc. (US)
BioControl Medical (Israel)

Please note: The report will take approximately 2 business days to prepare and deliver. Show more